Clinical Trial Update: Fetal Umbilical Cord Blood (UCB) Transplant for Lysosomal Storage Diseases [Phase 1]

View source ↗

Summary

Phase 1 fetal umbilical cord blood transplant trial for lysosomal storage diseases has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inborn Errors of Metabolism
• Lysosomal Storage Diseases

Snippet

Sponsor: Joanne Kurtzberg, MD | Conditions: Lysosomal Storage Diseases, Inborn Errors of Metabolism | Phase 1 | Status: WITHDRAWN